Condition
Chemoprevention
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 4 (1)
Trial Status
Withdrawn1
Unknown1
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06337253Phase 4Not Yet Recruiting
Seasonal Malaria Chemoprevention Rapid Assessment Study Mozambique
NCT04266353Not ApplicableWithdrawnPrimary
Effect of Resveratrol on Serum IGF2 Among African American Women
NCT04885426Not ApplicableUnknown
Metformin for the Prevention of CRA Recurrence
NCT00955149Phase 1Completed
Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)
Showing all 4 trials